Furthermore, in IBM patients, CD8+ T cells display increased expression of the killer-cell lectin-like receptor-1 (KLRG1), an inhibitory receptor that, upon engagement by its ligands E and N cadherins, negatively impacts cell proliferation (3). This evidence concerns the gene CD8A and inclusion body myositis.